Evaluation of community pharmacist follow-up supported by the use of healthcare technology for type 2 diabetes patients

• Egile Nagusiak: A. Lallemand (Egilea), C. Verrue (Egilea), A. Santi (Egilea), N. Delhaye (Egilea), M. Willaert (Egilea), A. Attipoe (Egilea), M. Tomas (Egilea), G. Philippe (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2023-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: Prevalence of type 2 diabetes is high in Belgium (estimated at over 10%, 1 patient out of 3 being unaware of their diagnosis). Management based on a change of lifestyle and the adoption of health-promoting behaviors, supplemented when needed with drug treatment, prevents complications, i...